Multiple Sclerosis Market Size, Drug Analysis, Epidemiology, Disease Management, Pipeline Assessment, Unmet Needs and Forecast to 2030
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Multiple Sclerosis Market Report Overview
Multiple sclerosis (MS) disease-modifying therapies (DMTs) market size across the 7MM was valued at $18.9 billion in 2020 and is expected to achieve a CAGR of more than 4% during 2020-2030.
Multiple Sclerosis Market Outlook, 2020-2030 ($ Billion)
To gain more information about the multiple sclerosis market forecast, download a free report sample
The multiple sclerosis market research report provides an analysis of the current and future market competition in the global MS therapeutics market. The report also offers an insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Market Size (2020) | $18.9 billion |
CAGR (2020 – 2030) | >4% |
Key Therapy Class | Non-Mab Injectable Therapies, Mab Injectable Therapies, and Oral Therapies |
Key Countries | The US, France, Germany, Italy, The UK, Spain, and Japan |
Leading Players | Biogen, Merck Serono (EMD Serono in the US), Teva, and Bayer HealthCare |
Multiple Sclerosis Market Drivers
The launch of efficacious pipeline products with convenient oral formulations or less-frequent dosing and the continued uptake of oral DMTs, which typically have a higher annual cost of therapy (ACOT) and improved compliance rates are the key factors driving the market growth. In addition, an increase in the number of DMT options that target progressive MS subtypes will also support market growth.
Multiple Sclerosis Market Segmentation by Therapy Class
Some of the key therapy classes in the multiple sclerosis market in the 7 MM are non-mAb injectable therapies, mAb injectable therapies, and oral therapies. Oral therapies had the highest share of the market in 2020 and is expected to continue its dominance during the forecast period. This growth is believed to result from the launch of pipeline oral DMTs that will increase the diversity of oral therapies and bring novel MOAs into the market.
Multiple Sclerosis Market Analysis by Therapy Class, 2020 (%)
For more therapy class insights into the multiple sclerosis market, download a free report sample
Multiple Sclerosis Market Segmentation by Countries
Some of the key countries in the multiple sclerosis market in the 7 MM are the US, France, Germany, Italy, the UK, Spain, and Japan. The US had the highest share of the market in 2020.
Multiple Sclerosis Market Analysis by Countries, 2020 (%)
For more countries’ insights into the multiple sclerosis market, download a free report sample
Multiple Sclerosis Market - Competitive Landscape
The leading players in the MS market are Biogen, Merck Serono (EMD Serono in the US), Teva, and Bayer HealthCare. Some of the successful product launches include Bayer’s Betaseron, Biogen’s Avonex, Teva’s Copaxone, and Merck’s Rebif.
Scope
- Overview of MS, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management.
- Annualized MS therapeutics market revenue, cost of therapy per patient, and treatment usage patterns in ≥20 years old patient segments forecast from 2020 to 2030.
- Pipeline analysis: comprehensive data assessing emerging trends and mechanisms of action under development for MS therapy. The most promising candidates in Phase III and IIb development are profiled.
- Analysis of the current and future market competition in the global MS therapeutics market. Insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping, and implications for the MS therapeutics market.
Key Highlights
- Report deliverables include a Word report and an Excel-based forecast model
- Forecast includes the 7 major markets (7MM)
- Forecast covers the period 2020-2030
Reasons to Buy
The report will enable you to:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global multiple sclerosis therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global multiple sclerosis therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships
Banner Life Sciences LLC
Bayer
Biogen GmbH
Bristol-Myers Squibb
Clene Nanomedicine Inc
Elan Pharmaceuticals
Genentech
Genzyme
Genmab GlaxoSmithKline AG
Immunic Inc
Janssen
Mapi Pharma Ltd
MediciNova Inc
Merck Serona Ltd
Novartis AG
Teva LLC
Roche
Sanofi
TG Therapeutics LLC
Table of Contents
Table
Figures
Frequently asked questions
-
What was the multiple sclerosis market size across the 7MM in 2020?
The multiple sclerosis market size across the 7MM was valued at $18.9 billion in 2020.
-
What is the multiple sclerosis market growth rate?
The multiple sclerosis market is expected to achieve a CAGR of more than 4% during 2020-2030.
-
What are some of the key therapy classes in the 7 MM multiple sclerosis market?
Some of the key therapy classes in the multiple sclerosis market in the 7 MM are non-mAb injectable therapies, mAb injectable therapies, and oral therapies.
-
What are some of the key countries in the 7 MM multiple sclerosis market?
Some of the key countries in the multiple sclerosis market in the 7 MM are the US, France, Germany, Italy, the UK, Spain, and Japan.
-
Who are the leading players in the MS market?
Some of the leading players in the MS market are Biogen, Merck Serono (EMD Serono in the US), Teva, and Bayer HealthCare.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.